Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria.
Saved in:
| Title: | Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria. |
|---|---|
| Authors: | Meidan R; Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Nadal MA; Servei Medicina Interna, Hospital Universitario Dr Joseph Trueta, Girona, Spain., Sosa BV; Servicio de Reumatologia, Hospital Universitario Jerez de la Frontera, Cadiz, Spain., Lareo UC; Servizo de Reumatoloxia, Complexo Hospitalario Universitario A Coruna, A Coruna, Spain., Mittal P; Department of Hematology, The Royal Free Hospital NHS Foundation Trust, London, UK., Cohen H; Department of Hematology, University College London Hospitals NHS Foundation Trust, London, UK., Isenberg D; Department of Ageing, Rheumatology and Regenerative Medicine, Division of Medicine, University College London, London, UK. |
| Source: | Lupus [Lupus] 2026 Aug; Vol. 35 (9), pp. 918-926. Date of Electronic Publication: 2026 May 06. |
| Publication Type: | Journal Article; Observational Study; Comparative Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
